Biologics to Treat Substance Use Disorders

Biologics to Treat Substance Use Disorders

Vaccines, Monoclonal Antibodies, and Enzymes

Montoya, Ivan D.

Springer International Publishing AG

01/2016

453

Dura

Inglês

9783319231495

15 a 20 dias

9132

Descrição não disponível.

Introduction.- PART I: Vaccines: Introduction.- Nicotine.- Cocaine.- Heroin.- Metamphetamine.- PART II: Monoclonal antibodies: Introduction.- Cocaine.- Metamphetamine.- PCP.- PART III: Enzymes: Introduction.- Butyrylcholinesterase.- Cocaine Esterase.- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines.- Nanotechnology based vaccines.- Protein Nanoparticles.- DNA Scaffolded Vaccines.- Single Hapten Conjugate Therapeutic Vaccine.- Vaccine Adjuvants.- Laser Adjuvant.- Peptide Conjugates & Cytokine Adjuvants.- T. brucei: A Platform for Immunization.- Vaccines for SUDs and HIV infection.- New Monoclonal Antibodies.- Protein Engineered for Controlled Duration of Action.- PART V: Ethical aspects of biologics to treat SUDs.

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

Biologics;Drug Addiction;Enzymes;Monoclonal Antibodies;Substance Abuse;Vaccines;psychopharmacology;pharmacotherapy